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. Indeed, extracellular NGF 6 levels are higher in inflamed joints and NGF blockade with both TrkA-IgG fusion protein and 7 NGF monoclonal antibodies produces analgesic effects in preclinical settings 3, 4 . Relevantly, 8 humanised monoclonal anti-NGF antibodies are effective analgesics in people with 9 osteoarthritis joint pain 5 . However, unexpected side effects such as increased incidence of 10 bone necrosis indicate that more studies are needed to understand NGF-mediated regulation 11 of osteoarthritis (OA) pain. 12
13
In this preclinical study we use intra-articular monoiodoacetate (MIA) injection as this OA 14 model is associated with dose-dependent and rapid pain-like responses in the ipsilateral limb, 15 which persists for several weeks. The ipsilateral joints display morphological changes of the 16 articular cartilage and bone disruption, which are reflective of some aspects of patient 17 pathology, as well as synovitis and macrophage infiltration 3, 6 . Furthermore, this model of OA 18 reflects specific changes in the NGF/TrkA system as follows: i) the TrkA antagonist AR786 19
shows both prophylactic and therapeutic anti-nociceptive efficacy in MIA rats 
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28
With the aim to investigate neuro-immune mechanisms mediated by NGF/TrkA signalling in 29 OA pain, we have examined the development of MIA-referred mechanical hypersensitivity and 30 joint pathology in wild type and mice carrying a mutation in the TrkA receptor in which Proline 31 782 is mutated to Serine. This TrkA mutation confers a defect on ubiquitination by Nedd4-2 32 (E3 ubiquitin ligase) which leads to i) an increase in NGF-mediated signalling; ii) 33 approximately 30% increase of dorsal root ganglia neurons; iii) increased sensitivity to noxious 34 hot and cold, but not mechanical, stimuli; iv) enhanced behavioural response to intraplantar 35 formalin and v) increased activation of spinal cord neurons after formalin 9, 10 . libitum. In all studies, experimental groups were randomized and an equal number of 3-6 44 months old-female and -male transgenic mice was used and data combined. Experiments 45 were performed blind. Sigma-Aldrich, I5154), dissolved in sterile saline were administered subcutaneously at 57 5mg/kg, every 5 days, starting from the day before MIA injections. HQL-79 (Tocris) was 58 dissolved in 0.5% methylcellulose. HQL-79 (3 and 10mg/kg) or vehicle was administered by 59 oral gavage. 60
61
Immunohistochemistry. Seven days after MIA injection, mice were perfuse-fixed under 62 terminal anaesthesia through the ascending aorta with heparinised saline followed by 4% 63 paraformaldehyde fixative solution with 1.5% picric acid in phosphate buffer (0.1M, pH 7.4, 64 PB). Sections from knee joints (30µm), lumbar spinal cord (20µm) and L3-L5 DRG (10µm) 65
were incubated overnight with sheep anti-calcitonin gene-related peptide (CGRP, 1:500, Enzo 66 Life Sciences). Spinal cord sections were incubated as follows: rabbit anti-c-Fos (1:1000, Cell 67 were sampled, in serial sections at a distance of at least 10 sections (i.e. 100 µm) apart. c-Fos 85 immunoreactivity was determined by counting number of positive profiles within a region 86 defined as laminae I and II, using Axiovision LE 4.8 software (Zeiss). Iba-1 and p-p38 87 immunoreactivity was determined by counting number of positive profiles within three 2.25 88 x10 4 µm 2 boxes in laminae I-III. Knee joint sections were examined at 10x magnification to 89 identify areas with the highest nerve fibre or cell density in the synovium. The length of nerve 90 fibres was determined by manually tracing them from Z-stack images using Axiovision LE 4.8 91 software (Zeiss) and reported as density of fibres per volume of synovium -area of synovium 92
x thickness (30µm) -as described previously 13 . CD117
+ mast cells were counted and data was 93 expressed as density of cells per volume of synovium 13 . 94
95
Western blotting. RBL-2H3 cells were homogenized in lysis buffer and 30 mg/ml of protein 96 was loaded on a 10% SDS-PAGE gel. Proteins were wet-transferred using the Bio-Rad 97 system (Bio-Rad Laboratories) and blots were probed overnight with rabbit anti-98 cyclooxygenase-2 (COX-2) (1:5000; Abcam), incubated with HRP-conjugated anti-rabbit 99 immunoglobulin (Dako) and visualised with BioSpectrum System (Ultra-Violet Products Ltd). 100
Bands were analysed with Quantity One (Bio-Rad Laboratories). β-actin (1:1000; Cell 101 Signaling) was used as loading control. 102
Flow cytometry. Seven days after OA induction, the skin and muscle were removed and the 104 knee joint isolated with care not to damage the bone and release bone marrow content. Knee 105 joints were digested in serum-free RPMI containing collagenase D (0.5µg/ml) and DNAse 106 (40µg/ml). Isolated cells were incubated with Fc block anti-mouse CD16/CD32 (Clone 2.4G2, 107 
ELISA. 126 127
Data Analysis. Data were tested for normal distribution (Shapiro-Wilk test) and analysed for 128 statistical differences using SigmaPlot 13.0 (Systat Software). For behavioural analysis, based 129 on our previous experience and data, in order to achieve alpha 0.05 and power 0.8 we used at 130 least 6 animals per group. Data analysis was performed by two-way repeated measures 131 ANOVA, followed by Tukey test. For immunohistochemical analysis, cell culture and FACS 132 analysis, in order to achieve alpha 0.05 and power 0.8 we used at least 4 samples per group 133 and data were analysed by one way ANOVA followed by Tukey test. The problem of family-134 wise error rate inflation (inherent in multiple testing) was controlled within each model using baseline values were comparable between TrkA KI and WT mice (Fig. 1A) . Furthermore, we 147 used a submaximal dose of MIA (0.7mg/mouse), which in WT mice was associated with slow 148 development of ipsilateral mechanical hypersensitivity starting from day 7 and lasting for up to 149 day 28 as compared to saline controls (Fig 1A) . We observed that mechanical hypersensitivity 150 developed more rapidly in TrkA KI and was significantly higher than in WT mice by day 3 post-151 MIA injection (Fig 1A) . Area under the curve (AUC) analysis demonstrated that withdrawal 152 thresholds of MIA-injected TrkA KI mice were lower than WT mice thresholds between days 0 153 and 7 (Fig. 1B) and days 21 and 28 after MIA injection (Fig. 1C) . 154
155
To confirm that nerve growth factor (NGF) contributed to mechanical hypersensitivity in TrkA 156 KI mice, we administered a tanezumab-like antibody that prevented the development of 157 mechanical hypersensitivity throughout the duration of the study (14 days) compared to 158 vehicle treatment ( Fig. 1D and E) . Similarly, the antibody prevented the development of 159 mechanical hypersensitivity in WT mice (Suppl. Fig. 1 ). 160
Consistent with an increased afferent input to the dorsal horn of the spinal cord in the MIA 161 model 6 , we counted more c-Fos-expressing neurons in ipsilateral laminae I-II at day 7 MIA 162 M A N U S C R I P T
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7 compared to saline ( Fig. 2A, B and E) . In addition, the number of c-Fos + cells was higher in 163
TrkA KI than WT dorsal horns (Fig. 2B, D and E) . Similarly, Iba-1 + microglial cell number was 164 higher in ipsilateral dorsal horn of MIA compared to saline WT mice (Fig. 2F , G and J) and 165 even higher in MIA-TrkA KI dorsal horns (Fig. 2G, I and J). Furthermore, phosphorylated p38 166 in Iba-1 + microglia was significantly higher in ipsilateral dorsal horn of MIA-compared to saline-167 treated TrkA KI mice (Fig. 2H, I As we were interested in exploring novel neuro-immune mechanisms that would involve the 177 NGF-TrkA signalling in the joint, we examined the extent of synovial inflammation, which is 178 associated with MIA pain phenotype more than cartilage degradation 3 . 179 180 Indeed, 7 days after MIA injection, no signs of cartilage degradation were observed in either 181 WT or TrkA KI joints (Fig. 3A) . However, both synovial volume and density of CGRP-182 expressing fibres were higher in MIA compared to saline groups (Fig. 3B , C, D and E). We 183 noticed that, under normal conditions (saline-treated mice), CGRP-fibres density in TrkA KI 184 was higher than in WT synovia (Fig. 3C, D 
and E). Consistent with higher expression of CGRP 185
in peptidergic fibres 9 , the cell bodies of TrkA KI sensory fibres expressed more CGRP than 186 WT fibres (Fig. 3F , G, H and I) and CGRP increased significantly 7 days after MIA injection in 187 both WT and TrkA KI (Fig. 3F, G, H and I ), suggesting that this peptide is up-regulated as a 188 result of MIA-induced inflammation in the joints. TrkA KI ipsilateral joints contained a significant higher numbers of leukocytes (CD45 + cells) 194 (Fig. 4B, D and E (Fig. 4B, D and G) . . Specifically, 12h after antigen (DNP-BSA)-dependent stimulation, a significant 217 increase of PGD 2 levels over basal values was quantified in the media (Fig. 6A) . The 218 presence of NGF with DNP-BSA in the culture media resulted in higher PGD 2 levels 8h after 219 antigen stimulation and levels remained elevated at the 12h time-point (Fig. 6A) . Thus, NGF 220 increases FC Ɛ RI-induced production of PGD 2 in culture and we know that PLA 2 is required for 221 NGF-induced delayed PGD 2 generation 12 .
We, therefore, we tested the effect of 222 phospholipase A 2 (PLA 2 ) inhibitor LY311727 on NGF-induced PGD 2 generation, 12h after 223 incubation -the time-point at which differences in PGD 2 generation between experimental 224 groups were more pronounced. LY311727 (1-100µM) inhibited NGF-induced PGD 2 225 generation, in a concentration-dependent manner (Fig. 6B) . Indeed, when cells were 226 stimulated with DNP-BSA and NGF, the levels of PGD 2 released in the media were higher 227 than when cells were stimulated with DNP-BSA alone (Fig. 6B) . The presence of 1µM 228 LY311727 had no effect on either DNP-BSA or DNP-BSA with NGF-induced PGD 2 generation 229 (Fig. 6B) . LY311727 (10µM) had no effect on DNP-BSA induced generation of PGD 2 but 230 reduced the level of PGD 2 generated by the antigen together with NGF (Fig. 6B) . At 100µM, 231 LY311727 reduced the generation of PGD 2 induced by both antigen and antigen together with 232 NGF (Fig. 6B) . 233
234
Whilst the initial phase of PGD 2 generation is dependent on constitutively expressed COX-1, 235 the second phase is dependent on the induction of COX-2 mRNA and protein 14, 16 . We, 236 therefore, quantified COX-2 after cells were incubated with DNP-BSA alone or together with 237 NGF and found that LY311727 (10µM) significantly reduced NGF-induced expression of COX-238 2, but not in cells incubated with antigen alone (Fig. 6C and D) . At 100µM, LY311727 reduced 239 COX-2 protein levels in cells stimulated with either antigen alone or antigen together with NGF 240 (Fig. 6C and D) . Altogether, these results confirm that NGF induces up-regulation of COX-2 241 that results in delayed PGD 2 formation in mast cells. 242
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PGD 2 synthase inhibitor HQL-79 prevents MIA-induced mechanical hypersensitivity in 244
TrkA KI mice 245 246 PGD 2 is known to exert pro-nociceptive effects through the activation of PGD 2 receptor 1 247 (DP 1 ) and 2 (DP 2 ) receptors expressed by sensory neurons, which potentiate the amplitude of 248 tetrodotoxin-resistant (TTX-R) Na + currents
17
. Therefore, NGF-induced production of PGD 2 in 249 mast cells could mediate the pro-nociceptive effect of NGF in TrkA KI joints in which a 250 significant number of mast cells are located in the vicinity of sensory neurons. To test this 251 possibility we evaluated the effect of the PGD 2 synthase inhibitor HQL-79 on MIA-induced 252 hypersensitivity. We used an inhibitor acting downstream of the PGD 2 synthesis cascade in 253 order to avoid non-specific effects on other bioactive prostaglandins. When WT and TrkA KI 254 mice were administered with either 3 or 10mg/kg of HQL-79 daily, for 8 days, starting from the 255 day of the MIA injection, we observed a dose-dependent reduction of mechanical thresholds 256 (Fig. 6E) . On the last experimental day the lowest dose of HQL-79 (3mg/kg) reversed MIA-257 induced hypersensitivity in TrkA KI, but not WT mice (Fig. 6E) . However, at the higher dose of 258 10mg/kg, HQL-79 induced similar reversal of MIA-induced mechanical hypersensitivity in TrkA 259 KI and WT mice (Fig. 6E) . Next, we evaluated whether HQL-79 treatment had affected PGD 2 260 synthesis in the damaged tissue and measured PGD 2 levels in knee joints lavages. We 261 observed that at 7 days after MIA injection, the levels of PGD 2 were significantly higher in 262
TrkA KI than WT joint lavages (Fig 6F) . After treatment with 3mg/kg of HQL-79, PGD 2 joint 263 levels were significantly lower than in vehicle treated, in TrkA KI but not in WT samples (Fig.  264   6F ). However, a higher dose of HQL-79 (10mg/kg) reduced PGD 2 levels in both WT and TrkA 265 KI joints (Fig. 6F ). These data indicate that an increased production of PGD 2 in the knee joint 266 is critical for the development of mechanical hypersensitivity in TrkA KI mice. TrkA activation on mast cells, sensitizing nociceptors via DP 1 receptor activation. The 282 pathway described here represents a novel signalling module that underlies interactions 283 between mast cells and nociceptive neurons in eliciting OA-pain hypersensitivity (Fig. 7) . Our 284 data indicate no occurrence of gender differences whereas significant gender variance applies 285 to immune cell response in the spinal cord after peripheral nerve injury 18 .
286
The knee joints are innervated by primary afferent fibres whose cell bodies are located in the 287 lumbar DRG 6, 19 . A significant proportion of these joint afferents, in both humans and animals 288 are peptidergic and some of them express TrkA receptors 19, 20 . Both CGRP and substance P 289 (SP) are up-regulated in DRG under peripheral inflammatory conditions as well as after MIA 290 injection in the knee, which also results in elevation of TrkA mRNA levels in DRG 19, 21 .We 291 observed that a TrkA mutation, which increases receptor signalling, is associated with a 292 . Together, these data suggest that engagement of the 307 NGF/TrkA system is associated with a spinal sensitization 7 . Relevantly, the spreading of pain 308 to sites distant from the joint has been reported in OA patients and central sensitisation is 309 believed to underlie such change 23, 24 . 310
311
There is increasing evidence that inflammation is present in synovial tissue of OA patients and 312 synovitis is associated with pain in human OA 23, 25 . Extracellular NGF at the periphery acts on 313
TrkA receptors expressed by peptidergic fibres, increasing inflammation and neuropeptide 314 release from sensory nerves 19, 26 . Furthermore, intra-articular NGF can increase synovitis and 315 the number of inflammatory cells, including macrophages and mast cells, in the synovium . NGF has been suggested to exert a direct role on mast cell development 328 and function and bone marrow derived mast cells from TrkA knock out mice show decrease 329 degranulation in comparison to bone marrow derived mast cells from control mice 28, 29 . NGF 330 can drive the synthesis of PGD 2 14, 16 , which is synthesised by COX-1 and 2, and is the main 331 prostaglandin released by mast cells. In this study, we observed that NGF induced PGD 2 332 production by mast cells through the induction of mast cell COX-1/2 expression. PGD 2 333 receptors, namely DP 1 receptors, are expressed by nociceptive fibres, where they can 334 increase CGRP release and bradykinin-induced SP release as well as the amplitude of TTX-R 335 sodium currents 17, 30 . Here we observed that a PGD 2 synthase inhibitor prevented both 336 development of MIA-induced mechanical hypersensitivity and PGD 2 accumulation in the knee 337 from cytoplasm to endoplasmic reticulum, where PLA 2 releases arachidonic acid (AA) from 538 membrane phospholipids and ii) by inducing expression of COX-2 which mediates the 539 synthesis of PGD 2 precursor PGH 2 from AA. PGD 2 can exert a pro-nociceptive effect through 540 the activation of DP 1 receptors expressed by sensory neurons, which activate sodium 541 channels thereby increasing afferent input to the dorsal horn of the spinal cord. 542
